Mutual Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.9M | Sell |
31,724
-2,728
| -8% | -$605K | 0.15% | 137 |
|
|
2025
Q4 | $7.87M | Buy |
34,452
+705
| +2% | +$161K | 0.17% | 118 |
|
|
2025
Q3 | $7.7M | Sell |
33,747
-1,066
| -3% | -$217K | 0.17% | 116 |
|
|
2025
Q2 | $6.62M | Buy |
34,813
+909
| +3% | +$169K | 0.17% | 132 |
|
|
2025
Q1 | $6.31M | Sell |
33,904
-46
| -0.1% | -$8.94K | 0.18% | 112 |
|
|
2024
Q4 | $5.9M | Sell |
33,950
-6,437
| -16% | -$1.18M | 0.17% | 114 |
|
|
2024
Q3 | $7.66M | Sell |
40,387
-531
| -1% | -$99.1K | 0.22% | 81 |
|
|
2024
Q2 | $7.44M | Sell |
40,918
-2,892
| -7% | -$479K | 0.22% | 86 |
|
|
2024
Q1 | $7.98M | Buy |
43,810
+771
| +2% | +$133K | 0.26% | 78 |
|
|
2023
Q4 | $6.67M | Sell |
43,039
-1,951
| -4% | -$284K | 0.23% | 87 |
|
|
2023
Q3 | $6.71M | Sell |
44,990
-3,743
| -8% | -$549K | 0.26% | 70 |
|
|
2023
Q2 | $6.57M | Sell |
48,733
-7,808
| -14% | -$1.14M | 0.25% | 82 |
|
|
2023
Q1 | $9.01M | Sell |
56,541
-89
| -0.2% | -$13.6K | 0.37% | 42 |
|
|
2022
Q4 | $9.15M | Buy |
56,630
+2,235
| +4% | +$343K | 0.41% | 38 |
|
|
2022
Q3 | $7.3M | Buy |
54,395
+9,526
| +21% | +$1.37M | 0.38% | 49 |
|
|
2022
Q2 | $6.87M | Buy |
44,869
+1,243
| +3% | +$190K | 0.46% | 39 |
|
|
2022
Q1 | $7.07M | Sell |
43,626
-1,289
| -3% | -$187K | 0.4% | 48 |
|
|
2021
Q4 | $6.08M | Buy |
44,915
+2,504
| +6% | +$296K | 0.32% | 64 |
|
|
2021
Q3 | $4.58M | Buy |
42,411
+1,320
| +3% | +$151K | 0.27% | 85 |
|
|
2021
Q2 | $4.63M | Buy |
41,091
+621
| +2% | +$69.9K | 0.27% | 86 |
|
|
2021
Q1 | $4.38M | Buy |
40,470
+756
| +2% | +$80.9K | 0.3% | 76 |
|
|
2020
Q4 | $4.25M | Buy |
39,714
+1,815
| +5% | +$174K | 0.32% | 65 |
|
|
2020
Q3 | $3.32M | Sell |
37,899
-6,259
| -14% | -$589K | 0.29% | 77 |
|
|
2020
Q2 | $4.33M | Buy |
44,158
+4,971
| +13% | +$438K | 0.43% | 49 |
|
|
2020
Q1 | $2.99M | Buy |
39,187
+2,471
| +7% | +$210K | 0.41% | 51 |
|
|
2019
Q4 | $3.25M | Buy |
36,716
+21,400
| +140% | +$1.78M | 0.35% | 61 |
|
|
2019
Q3 | $1.16M | Sell |
15,316
-923
| -6% | -$63.3K | 0.15% | 160 |
|
|
2019
Q2 | $1.18M | Buy |
16,239
+2,734
| +20% | +$215K | 0.15% | 170 |
|
|
2019
Q1 | $1.09M | Buy |
13,505
+144
| +1% | +$11.8K | 0.16% | 156 |
|
|
2018
Q4 | $1.23M | Sell |
13,361
-322
| -2% | -$28.3K | 0.24% | 101 |
|
|
2018
Q3 | $1.29M | Sell |
13,683
-711
| -5% | -$67.4K | 0.2% | 128 |
|
|
2018
Q2 | $1.33M | Sell |
14,394
-335
| -2% | -$32.7K | 0.3% | 100 |
|
|
2018
Q1 | $1.39M | Buy |
14,729
+10,557
| +253% | +$1.16M | 0.35% | 81 |
|
|
2017
Q4 | $403K | Buy |
+4,172
| New | +$393K | 0.15% | 182 |
|
Other funds holding ABBV
VCM
VPM
Mutual Advisors's ABBV Position: Q1 2026 in Review
Mutual Advisors reduced its AbbVie (ABBV) stake by 7.9% in Q1 2026, selling an estimated $605K and leaving 31,724 shares worth $6.9M. The position accounts for 0.15% of the portfolio, ranked #137.
Mutual Advisors first reported a position in ABBV in Q4 2017 and has held it in 34 quarters since. The position peaked at $9.15M in Q4 2022. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Mutual Advisors held 31,724 shares of AbbVie worth $6.9M as of Q1 2026.
- Mutual Advisors sold 2,728 AbbVie shares in Q1 2026, an estimated $605K.
- AbbVie made up 0.15% of Mutual Advisors's portfolio in Q1 2026, its #137 holding.
- Mutual Advisors first reported a position in AbbVie in Q4 2017 and has held it in 34 quarters since.
- Mutual Advisors's AbbVie position peaked at $9.15M in Q4 2022.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Mutual Advisors's 13F filing for Q1 2026, filed 4 May 2026.